Drugs / PRX167700
last change Apr 2015 re-read 3 minutes ago

PRX167700

Developed for
osteoarthritis, knee
Investigated by
Proximagen Limited

Trials 1

20142015201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 2 NCT01945346 Sep 2013 → Apr 2015 osteoarthritis, knee Proximagen Limited Completed No outcome recorded

Evidence & citations 2 cited values

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as PRX167700 ClinicalTrials.gov intervention name — accepted as the source's own label NCT01945346 ↗
Route Oral “Oral capsule” NCT01945346 ↗